Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial. Radiology. 2017 05; 283(2):450-459.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Endometrial Neoplasms
Endometrial Neoplasms
Female
Female
Fluorodeoxyglucose F18
Fluorodeoxyglucose F18
Humans
Humans
Lymph Nodes
Lymph Nodes
Lymphatic Metastasis
Lymphatic Metastasis
Middle Aged
Middle Aged
Positron Emission Tomography Computed Tomography
Positron Emission Tomography Computed Tomography
Radiopharmaceuticals
Radiopharmaceuticals
Reproducibility of Results
Reproducibility of Results
Retroperitoneal Neoplasms
Retroperitoneal Neoplasms
Risk Assessment
Risk Assessment
Sensitivity and Specificity
Sensitivity and Specificity
authors with profiles
Robert S Mannel
Michael A Gold